Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route

This study evaluated a vaccine made from crude rhoptry proteins of Toxoplasma gondii with Quil-A, which was administered to cats by the intranasal route. Eleven short-hair domestic cats were divided into four groups: G1 (n=3) received three doses (200 microg/dose) of the rhoptry vaccine with Quil-A (20 microg); G2 (n=3) received PBS with Quil-A (20 microg); G3 (n=3) and G4 (n=2) received only PBS. Treatments were administered at days 0, 21, and 42 by the intranasal route. Challenge was done to G1, G2, and G3 animals with 600 cysts of the VEG strain on day 51 (challenge day); G4 animals were unchallenged. The anti-T. gondii IgG and IgA antibody levels from sera were measured by indirect enzyme-linked immunosorbent assay (ELISA). At challenge, two animals from G1 revealed antibody levels for both IgG and IgA; oocysts were not detected in feces of these two cats. There were no differences in hematological values between groups throughout the experiment (p>0.10). Preventable fractions were 67% in G1 and 0% in G2 and G3. Comparatively, G1 animals shed 89.3% and 90.8% less oocysts than G3 and G4, respectively. Two out of three cats were protected against T. gondii oocyst shedding when the rhoptry vaccine was administered by the intranasal route. This is the first study using crude rhoptry proteins as vaccine by the intranasal route in cats to evaluate protection against oocysts shedding.     

Humoral and cellular immune responses in pigs immunized intranasally with crude rhoptry proteins of Toxoplasma gondii plus Quil-A

We evaluated the humoral and cellular immune responses in pigs immunized intranasally with crude rhoptry proteins of Toxoplasma gondii plus Quil-A. The experiment used 13 mixed-breed pigs divided into the following three groups: G1 (vaccinated-challenged, n=6), which received the rhoptry vaccine (200(g/dose); G2 (adjuvant-challenged, n=4), which received PBS plus Quil-A; and G3 (unvaccinated-challenged, n=3), which was the control group. The treatments were performed intranasally at days 0, 21, and 42. Three pigs from G1 produced IgG and IgM antibody levels above the cut-off in the ELISA on the challenge day. Partial protection was observed in G1 at the chronic phase of infection when compared with G3. The preventable fractions were 41.6% and 6.5%, in G1 and G2, respectively. The results of this study suggest that rhoptry proteins plus Quil-A stimulated humoral, local, and systemic immune responses, which were able to partially protect the brain from cyst formation.     

Protective immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii

The RH strain of Toxoplasma gondii is highly virulent; 1 infective organism is uniformly lethal for mice. Three pigs inoculated SC with 10(3) tachyzoites of the RH strain developed fever, but otherwise remained normal, and T gondii was not demonstrated in their tissues by bioassay into mice. To determine whether vaccination with the RH strain could induce protective immunity to oral challenge with T gondii oocysts, 12 pigs were divided into 3 groups (A, B, C) of 4 pigs each. Pigs in groups A and B were inoculated IM with 10(6) tachyzoites of the RH strain and 4 pigs in group C served as uninoculated controls. Except for fever, the pigs remained clinically normal after inoculation with the RH strain and T gondii was not found by bioassay in mice of tissues from 4 pigs euthanatized 64 days after inoculation. Pigs in groups B and C were challenge-inoculated orally with 10(4) (4 pigs) or 10(5) (4 pigs) T gondii oocysts 72 days after vaccination with the RH strain. The previously uninoculated pigs developed fever, anorexia, and diarrhea from 3 to 8 days after the oocyst challenge. One of the 2 pigs given 10(5) oocysts became moribund because of toxoplasmosis and was euthanatized 9 days after inoculation. Pigs vaccinated with the RH strain remained free of clinical signs after challenge with oocysts. Results of the bioassays indicated that fewer tissue cysts developed in the RH strain-vaccinated pigs than in the previously uninoculated control pigs.     

Long-term persistence of Toxoplasma gondii in tissues of pigs inoculated with T gondii oocysts and effect of freezing on viability of tissue cysts in pork

To study the distribution of tissue cysts in porcine tissues, 16 pigs were fed oocysts of 4 strains of Toxoplasma gondii (4 pigs/strain). Pigs were euthanatized between postinoculation days 103 and 875 and portions of 5 to 14 organs were bioassayed in mice and/or cats for T gondii. For bioassays, 50- to 100-g portions of tissue were incubated in acidic pepsin solution to free bradyzoites from cysts in parenchyma, and washed sediment from the digests of each specimen was inoculated SC into mice (6 mice/organ). For bioassays in cats, a 500-g portion or whole organ was fed to Toxoplasma-free cats (1 cat/organ). Toxoplasma gondii was recovered from tissues of 14 of the 16 pigs (from the brains of 12, hearts of 11, tongues of 10, and diaphragms of 6). Toxoplasma gondii was isolated from commercial cuts of meat from 5 infected pigs; from the arm picnic and ham of 3, Boston butt, spareribs, and tenderloin of 2, and bacon and tailbone of 1. Regarding the 4 pigs euthanatized between postinoculation days 759 and 865, cats shed T gondii oocysts after the ingestion of hearts of all 4; tongues of 3; bacons, hams, arm picnics, Boston butts, spareribs, and diaphragms of 2; and livers, kidneys, and tenderloins of 1. Toxoplasma gondii was found to be inconsistently distributed among the organs and muscles, but overall, tongue and heart were more heavily infected than were other tissues. Tissue cysts in pork were rendered nonviable at -12 C for 3 days.     

Correlation of tissue infection and serologic findings in pigs fed Toxoplasma gondii oocysts

Each of thirteen 6-week-old pigs was inoculated per os with 10,000 sporulated oocysts of Toxoplasma gondii. By postinoculation day (PID) 13, pigs were seropositive by the indirect fluorescent antibody test. Beginning on PID 13 and every 7 days thereafter through PID 97, 1 pig was killed and 6 tissues were examined for T gondii. Of the 13 pigs, 11 were infected, including the 1st pig killed on PID 13, although none of the pigs had gross lesions of toxoplasmosis. Tissues harboring T gondii most frequently were the heart and brain; organisms were detected less frequently in the longissimus muscles, diaphragm, and liver. Toxoplasma gondii was not detected in the bronchial lymph nodes. There was good correlation between antibody and presence of T gondii in these pigs. One additional pig, maintained as a noninfected control, remained seronegative and had no evidence of infection when killed on PID 97.     

Effect of irradiation on the viability of Toxoplasma gondii cysts in tissues of mice and pigs

Muscles from tongue, heart, and limbs of 14 pigs inoculated orally with Toxoplasma gondii oocysts were irradiated with 10, 20, 25, and 30 krad of gamma (cesium-137 and cobalt-60) irradiation. Viability of T gondii cysts was assayed by feeding porcine muscles to T gondii-free cats and/or by inoculation of sediment from acid-pepsin digested porcine muscle into mice. Cats fed 500-g samples of muscles irradiated with up to 20 krad shed T gondii oocysts. Cats fed muscles irradiated with 25 or 30 krad did not shed oocysts. Mice were inoculated with 8 isolates of T gondii, and tissue cysts in their brains irradiated with up to 40 krad were infective to mice; however, there was a 10,000-fold reduction in the viability of organisms in tissue cysts irradiated with 40 krad, compared with that in nonirradiated cysts. At 50 krad of gamma irradiation, there were no detectable infective organisms in infected mouse brains.     

Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1

Numerous studies have supported the importance of immunity to SAG1, the most predominant antigen of Toxoplasma tachyzoite, in protection against Toxoplasma gondii infection. Nevertheless, vaccination with SAGI provides insufficient protection when compared with that of Toxoplasma lysate (TL). In order to screen the Toxoplasma antigens for immunogenic potential shown by modified protection or induction of specific immune response after infection, recombinant antigens were prepared in Eschericha coli using DNA fragments corresponding to SAG1, SAG2, SAG3, SRS1 and P54 of T. gondii RH strain maintained in our laboratory. Each of the recombinant antigen products or a mixture of the five antigens (Mix) was used to vaccinate mice. Mice then received a lethal dose of T. gondii. Up to 25% of the mice vaccinated with SAG2, SRS1, P54 and Mix survived, whereas there were no survivors in gene 10- (negative control), SAG1- and SAG3- vaccinated groups. In all the survivors, brain cysts were not observed. Conversely, vaccination with TL almost completely protected mice in the acute phase but permitted brain cyst formation and resulted in gradual decrease of survivors to 33% during 4 months of experiments. Western blot analysis on convalescent sera showed an extensive IgG induction to a 30 kDa antigen in TL-vaccinated mice, a 22 kDa in SAG2-vaccinated mice and a 55 kDa in P54-vaccinated mice. The protection modified by boost in specific antibody is suggestive of the immunogenic potential of SAG2, SRS1 and possibly P54 against T. gondii infection.     

Toxoplasma gondii cysts in placentas of experimentally infected sheep

To determine the presence of tissue cysts in ovine placentas, 6 ewes were inoculated orally with 10,000 Toxoplasma gondii oocysts at 60 days of gestation. The ewes were euthanatized and necropsied 21, 52, 56, 57, 57, and 62 days after T gondii inoculation, and placental cotyledons from each ewe were collected and homogenized. To distinguish between the presence of tachyzoites that are killed by acid pepsin solution and bradyzoites (from cysts) unaffected by this solution, a portion of each homogenate was inoculated into mice and another portion was inoculated into mice after digestion in acid pepsin solution. Toxoplasma gondii was isolated in 26 of 34 (76.4%) of mice inoculated with nondigested placentas of all 6 ewes and in 16 of 34 (47%) mice inoculated with digested placenta of 5 of 6 ewes. Seemingly, cysts do occur in placental tissue, but the digestion method was inferior, compared with the nondigestion method for recovery of T gondii from placenta.     

ELISA for assessing Toxoplasma gondii antibodies in pigs

The ELISA technique was applied to assess Toxoplasma gondii antibodies in pigs. Among 925 swine examined 36.4 per cent of the animals were seropositive. Serum titres ranged from 100 to 3,200.     

弓形虫蛋白质二硫键异构酶的免疫保护作用

为了探讨皮下免疫弓形虫蛋白质二硫键异构酶(TgPDI)对弓形虫急性感染的保护作用,本试验通过原核表达获取了重组TgPDI,将纯化并去除内毒素的重组蛋白皮下免疫昆明小鼠,利用ELISA方法监控抗体水平变化,通过实时荧光定量PCR检测感染小鼠的组织载虫量并记录小鼠存活时间,评价TgPDI的免疫保护作用。结果显示,免疫重组TgPDI可以有效刺激小鼠产生抗体(1∶16 000);免疫该蛋白可以极显著抑制弓形虫感染小鼠血液、肝脏、脾脏和脑组织中的弓形虫增殖(P0.01),并能延长小鼠感染后的存活时间。结果表明,皮下免疫重组TgPDI可以刺激小鼠产生保护性免疫应答,TgPDI是预防弓形虫感染的免疫候选分子。     

Persistence of encysted Toxoplasma gondii in tissues of pigs fed oocysts

Ten pigs were fed 100 to 10,000 Toxoplasma gondii oocysts. Two pigs died 7 and 11 days later, and 8 pigs were euthanatized at days 38, 38, 91, 126, 168, 169, 170, and 171. From the euthanatized pigs, portions of 15 organs digested in pepsin-HCl solution were inoculated into mice, as a bioassay for viable T gondii. Such organisms were isolated from the brain and heart of these 8 pigs, from the tongue of 7, from thigh muscles of 5, from the diaphragm of 4, from kidneys, liver, and small intestines of 2, and from salivary glands and eyes of 1 pig; but not from lungs, spleen, spinal cord, mesenteric and prescapular lymph nodes of any pig. Results indicate that T gondii can persist in edible tissues of living pigs for at least 171 days and that heart and brain may be the most suitable porcine tissues for epizootiologic surveys.     

刚地弓形虫PTS核酸疫苗的构建及免疫保护力评价

旨在构建弓形虫磷脂酰苏氨酸合成酶(Toxoplasma gondii phosphatidylthreonine synthase,PTS)基因DNA疫苗,评价其抗弓形虫的免疫保护力。利用RT-PCR技术扩增得到弓形虫PTS基因,构建真核表达质粒pVAXTgPTS,然后转染HEK 293-T细胞,分析pVAX-TgPTS在细胞中的表达情况。利用真核表达质粒pVAX-TgPTS对BABL/c小鼠进行3次免疫,并用空质粒pVAX1作为对照,在每次免疫前和第3次免疫后2周收集小鼠血清,经ELISA方法检测小鼠血清中的IgG水平。第3次免疫后2周每组取3只小鼠,将其剖杀取脾脏,CCK-8法检测脾淋巴细胞增殖能力,流式细胞仪测定CD4+和CD8+T细胞百分比。小鼠脾细胞经STAg刺激后,利用ELISA试剂盒检测脾细胞细胞因子的表达情况。第3次免疫后2周,每只小鼠腹腔注射1 000个弓形虫RH株速殖子,观察记录小鼠的存活时间。结果显示,pVAX-TgPTS能够在HEK 293-T细胞中表达;第3次免疫后2周pVAX-TgPTS组血清中IgG含量相比对照组有了显著提高;pVAX-TgPTS组淋巴细胞刺激指数(SI)略微高于对照组;CD4+和CD8+T细胞百分比含量明显高于对照组;pVAX-TgPTS组中脾细胞经STAg刺激后能够明显提高IFN-γ的表达量。攻虫试验结果表明,pVAX-TgPTS组小鼠存活时间比对照组明显增长。本试验成功构建真核表达质粒pVAX-TgPTS,证明pVAX-TgPTS能够诱导小鼠产生一定的体液免疫和细胞免疫反应,并对弓形虫感染产生一定程度的免疫保护力,该研究结果为进一步研发弓形虫核酸疫苗奠定基础。     

Evaluation of three novel azasterols against Toxoplasma gondii

Previous studies from our group have demonstrated the high susceptibility of Toxoplasma gondii tachyzoites to the sterol analogues 22,26-azasterol and 24,25-(R,S)-epiminolanosterol. In this work we present data on testing in vitro three novel azasterols as potential agents for the treatment of toxoplasmosis. The three compounds inhibited parasite growth at micromolar concentrations, in a dose-dependent manner. Electron microscopy analysis of intracellular tachyzoites after treatment with the most effective compound showed drastic mitochondrion swelling associated with the appearance of an electron-lucent matrix and disrupted cristae. Parasite lysis also took place. The appearance of electron dense cytoplasmic structures similar to amylopectin granules distributed throughout the parasite suggests that azasterols might be inducing differentiation of those tachyzoites which were not lysed to the bradyzoite stage.     

Immune response and protective efficacy against homologous challenge in BALB/c mice vaccinated with DNA vaccine encoding Toxoplasma gondii actin depolymerizing factor gene

A DNA vaccine (pVAX1-TgADF) encoding Toxoplasma gondii actin depolymerizing factor (ADF) gene was constructed and the immune response and protective efficacy of this vaccine against homologous challenge in BALB/c mice were evaluated. High titers of specific antibody and increases in the percentage of CD4(+) and CD8(+) T lymphocyte cells were observed from BALB/c mice vaccinated with pVAX1-TgADF (P<0.05), when PBS group was used as control. The survival time of BALB/c mice in pVAX1-TgADF group was longer than those in control groups. The numbers of brain cysts in the experimental BALB/c mice immunized with pVAX1-TgADF reduced significantly compared with those in PBS group (P<0.05), and the rate of reduction could reach to around 42.8%. These results suggested that the DNA vaccine pVAX1-TgADF could generate specific humoral and cellular immune responses, prolong survival times, and reduce brain cysts load against T. gondii infection in BALB/c mice.     

桧烯抗弓形虫活性的体外评价

本研究旨在筛选具有抗弓形虫活性的萜类化合物,并进行体外活性评价。对26个萜类化合物进行体外抗弓形虫增殖作用的筛选,采用CCK-8法确定活性化合物对Vero细胞的毒性和安全浓度,Giemsa染色进一步确定对弓形虫的活性,通过细胞免疫荧光、Giemsa染色和生物化学发光法评价活性化合物对弓形虫的体外活性。结果表明,26个萜类化合物中,桧烯对弓形虫有显著的活性,桧烯对RH-2F的IC₅₀为90.76 μg·mL^-1,Giemsa染色和细胞免疫荧光的结果表明,桧烯对细胞内的两种弓形虫虫株都有显著的抗增殖作用,并且对弓形虫的入侵有极显著的抑制作用（P<0.001）。综上表明,桧烯对弓形虫的入侵和细胞内增殖具有显著的抑制作用,可作为潜在的抗弓形虫先导化合物。     

Prevalence of antibodies against Toxoplasma gondii in roe deer from Spain

Roe deer (Capreolus capreolus) is an important game animal in Spain. Sera from 278 roe deer from eight areas in mainland Spain were assayed for antibodies to Toxoplasma gondii by modified agglutination test (MAT). Titers of 1:25 or higher were found in 109 (39.2%) of 278 deer. No significant differences in antibody prevalence were found between sex or age categories. In contrast, significant differences in seroprevalence between locations were evident. Roe deer from the Northern coastal habitats (high humidity and roe deer density) had the highest prevalence, compared with low prevalence in Central Spain (arid areas and low roe deer density). There was a positive correlation between antibody prevalence and mean annual rainfall (r(s)=0.85, n=8, P<0.01). These findings have environmental and/or public health implications because venison can be an important meat source of T. gondii infections for humans and feral cats.     

Seroprevalence of Toxoplasma gondii in wild pigs (Sus scrofa) from Spain

Sera collected from 507 hunter-killed wild pigs (Sus scrofa) between 1993 and 2004 from five geographic regions in northern Spain and seven regions in southern Spain were assayed for antibodies to Toxoplasma gondii by the modified agglutination test (MAT). Antibodies to T. gondii were detected in 185 (38.4%) of 507 pigs with titers of 1:25 in 71, 1:50 in 111 and > or =1:500 in 3; seroprevalence was significantly higher (P<0.05) in pigs from southern regions. Seroprevalence was density dependent; it was higher in pigs from high stocking per hectare and availability of forage. Statistically significant differences were not observed between T. gondii seroprevalence and hunting estates (open versus fenced), sex or age. Serological results indicate a widespread exposure to T. gondii among Spanish wild boars, suggesting that this population could represent a public health risk for persons that handle or consume raw or undercooked infected wild pig meat.